Navigation Links
Battelle to Perform Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process
Date:10/28/2008

CAMBRIDGE, Mass. and COLUMBUS, Ohio, Oct. 28 /PRNewswire/ -- IntelligentMDx a developer and manufacturer of proprietary nucleic acid assays, today announced that it is working with the Battelle Eastern Science and Technology (BEST) Center to conduct assay performance verification studies of its nucleic acid-based diagnostic or 'smart' molecular diagnostic assays.

Under terms of the agreement Battelle will perform various testing of IntelligentMDx's Quantitative BK Virus (BKV) Real-Time PCR Assay to identify its performance characteristics. Financial terms of the agreement were not disclosed.

BKV has recently emerged as an important pathogen in nephropathy in kidney transplant patients and hemorrhagic cystitis in human stem cell transplant patients. The IntelligentMDx Quantitative BK Virus Real-Time PCR Assay can be utilized to track the course of infection and monitor response to treatment.

The biggest hurdle for a nucleic acid testing is that current reagent design methods do not specifically address the core set of challenge affecting reagent performance -- such as genetic diversity and other key performance metrics. IntelligentMDx has a proprietary process to manage the design, development and manufacturing of pathogen assays that are platform agnostic and adaptable to all nucleic acid detection methodologies. The IntelligentMDx process allows for rapid time to market.

About IntelligentMDx

IntelligentMDx(TM) develops and manufactures tests, under regulatory compliance, for a broad range of molecular based systems for use in clinical molecular diagnostics, drug development and applied science applications. Our mission is to rapidly translate the needs of the clinician, patient and partners into very specific, highly sensitive, robust clinically impactful tests, thus enabling caregivers worldwide to provide care with certainty(SM).

IntelligentMDx's competitive advantage incorporates intelligent software with assay de
'/>"/>

SOURCE IntelligentMDx
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Battelle and YuYu Pharma Create the First Joint Bioequivalence Test Experimentation Institution
2. NYC-area 1st: Morgan Stanley Childrens Hospital performs transcatheter pulmonary valve replacement
3. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
4. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
5. End-to-End HR Performance Benchmarks: Metrics That Will Help Turn the HR Cost Center into a Productivity Driver
6. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
7. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
8. Physician Team at Northwestern Memorial Performs Rare Oral Gallbladder Removal
9. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
10. The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers
11. New Device for Clearing Blocked Arteries in the Legs Receives FDA Clearance for Peripheral Use - Procedures Performed Across the US Within First 48 Hours

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...OAKLAND, Calif., Dec. 4 Herpes zos...ildren who have been vaccinated against chicken po...ecember issue of the Pediatric Infectious Disease...nd, used electronic health records to identify mor...lla (chicken pox) vaccine from 2002 to 2008 in Kai...
(Date:12/3/2009)... With a membership increase of more th...vement not only as a milestone in its history, but...nce. Most associations are experiencing a decline ...uo;At a time when trade organizations across the n... experiencing unprecedented growth, signaling that...
(Date:12/3/2009)...PLAINSBORO, N.J., Dec. 3 The devel...t Plainsboro (UMCPP) reached a milestone today wit... of steel-frame construction at the new hospital t...ceton (UMCP). ,, (Photo: http://www.newscom.co...out ceremony is a steelworkers, tradition in which...
(Date:12/3/2009)... BEIJING, Dec. 3 /PRNewswire-Asia/ -- Long beli...er, one of the most important ingredients in globa...ng this flu season. , The timing of this ...ages,effecting upward price pressures in a way th...eat of the current demand hysteria over garlic. Ga...
(Date:12/3/2009)...SHINGTON, Dec. 3 The Am...ging (AAHSA) commends the Senate for passing Sen. ...res seniors by protecting guaranteed benefits, and...e program. ,, "With the silver tsunami of retir...for health care reform legislation currently befor...
Breaking Medicine News(10 mins):Health News:Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 2Health News:Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 3Health News:Florida Medical Association Marks Record Membership Growth 2Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 2Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 3Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 4Health News:Ginger Prices Could Skyrocket on H1N1 Fears 2
...peace of mind to those living with food allergies,... that 12,million Americans suffer from food allerg...irely, or face the risk of suffering severe or eve...hat help,alert others to an allergy issue., "We f...
...nting, firefighting also examined by international... A study by the,World Health Organization has foun...er in humans. The study found that after prolonged...ce prostate,cancer., "Shift work that interferes ...
...nts Launches OR-Live Information Resource Portal t...raumatic Event -, NEW YORK, Nov. 30 A dynamic pa...patient/advocate assembled this week at a,forum fo...due to today,s release of the movie "AWAKE." The f...
... cancer with intensity modulated radiation therapy...life of patients compared to conventional radiatio...ber 1 issue of the International Journal for Radia...eferred to as throat cancer, is a cancer that deve...
...damage to the knees, cushioning elements, study su...ge to the menisci -- the knees, "shock absorbers" ...s, but it does not directly provoke pain, aching a... damage are related to osteoarthritis, and not bec...
...atients comes to harm while in hospital as a resul...ity and Safety in Health Care. , The findings are...ample of just over 1000 patients admitted to one l...es, however, say the authors. , The researchers u...
Other Medicine News:Health News:AllerNotes Help Take Food Allergies Off the Table 2Health News:WHO Study: Night Shift Work May Cause Cancer 2Health News:Experts Agree That One Case Is Too Many; Tackle Tough Issue of Anesthesia Awareness 2Health News:Experts Agree That One Case Is Too Many; Tackle Tough Issue of Anesthesia Awareness 3Health News:Experts Agree That One Case Is Too Many; Tackle Tough Issue of Anesthesia Awareness 4Health News:Newer radiation treatment easier for some throat cancer patients 2Health News:Study Probes Source of Knee Arthritis Pain 2Health News:1 in 10 patients comes to harm while in hospital 2
(Date:12/3/2009)...-USNewswire/ -- In response to the increasingly cr... in the evolving healthcare delivery system, Duke ...formatics (DCHI) to provide a campus focus for hea...nterdisciplinary approach to education that will p...healthcare administrators with an expertise in the...
(Date:12/3/2009)...irstCall/ -- Cardium Therapeutics (NYSE Amex: CXM...y, Tissue Repair Company, submitted a 510(k) prema...ug Administration (FDA) seeking marketing clearanc...on positive data from the Company,s recently compl...ission with the FDA covers Excellagen XL(TM) and ...
(Date:12/3/2009)...e/ -- Apnex Medical, Inc., a private medical devic...d round of private equity financing totaling $14 m...cal study and develop a second generation of its p...t obstructive sleep apnea (OSA). ,, Participant...Enterprise Associates (NEA), Polaris Venture Partn...
Breaking Medicine Technology:Duke Medicine to Train Healthcare Professionals in Health Informatics 2Duke Medicine to Train Healthcare Professionals in Health Informatics 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5Apnex Medical, Inc. Raises Additional $14 Million 2Apnex Medical, Inc. Raises Additional $14 Million 3Medical professionals from developing nations to pursue hematology training 59231 1Medical professionals from developing nations to pursue hematology training 59231 2Face Masks for Patients May Leak Spread Germs 59226 1Face Masks for Patients May Leak Spread Germs 59226 2Gene Data Tool Advances Prospects for Personalized Medicine 59221 1Gene Data Tool Advances Prospects for Personalized Medicine 59221 2Gene Data Tool Advances Prospects for Personalized Medicine 59221 3
...ynvista Therapeutics, Inc. (NYSE Alternext US: SYI... clinical development portfolio and its current fi...ent have determined that it is in the best interes...ing the value of its diagnostic assets and to term...andidates alagebrium and SYI-2074, including the f...
...an. 28 Impact Medical Solutions, Inc. (OTC Bullet...ounced today that Mr. Mark A. Billings has joined ... a founding Partner at Atwater Financial Group Inc...at provides corporate finance advisory services to...d CEO of Orex Exploration Inc., a junior gold expl...
Other Medicine Technology:Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update 2Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update 3Impact Medical Solutions Announces Appointment of New Director and Corporate Update 2Impact Medical Solutions Announces Appointment of New Director and Corporate Update 3
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
Medicine Products: